171 related articles for article (PubMed ID: 20568658)
1. Increase in brain-derived neurotrophic factor in first episode psychotic patients after treatment with atypical antipsychotics.
González-Pinto A; Mosquera F; Palomino A; Alberich S; Gutiérrez A; Haidar K; Vega P; Barbeito S; Ortiz A; Matute C
Int Clin Psychopharmacol; 2010 Jul; 25(4):241-5. PubMed ID: 20568658
[TBL] [Abstract][Full Text] [Related]
2. Brain-derived neurotrophic factor serum and plasma levels in the treatment of acute schizophrenia with olanzapine or risperidone: 6-week prospective study.
Kudlek Mikulic S; Mihaljevic-Peles A; Sagud M; Bajs Janovic M; Ganoci L; Grubisin J; Kuzman Rojnic M; Vuksan Cusa B; Bradaš Z; Božina N
Nord J Psychiatry; 2017 Oct; 71(7):513-520. PubMed ID: 28671000
[TBL] [Abstract][Full Text] [Related]
3. BDNF and S100B in psychotic disorders: evidence for an association with treatment responsiveness.
van de Kerkhof NW; Fekkes D; van der Heijden FM; Verhoeven WM
Acta Neuropsychiatr; 2014 Aug; 26(4):223-9. PubMed ID: 25142290
[TBL] [Abstract][Full Text] [Related]
4. Antipsychotic treatment in child and adolescent first-episode psychosis: a longitudinal naturalistic approach.
Castro-Fornieles J; Parellada M; Soutullo CA; Baeza I; Gonzalez-Pinto A; Graell M; Paya B; Moreno D; de la Serna E; Arango C
J Child Adolesc Psychopharmacol; 2008 Aug; 18(4):327-36. PubMed ID: 18759642
[TBL] [Abstract][Full Text] [Related]
5. Brain-derived neurotrophic factor as a biomarker for cognitive recovery in acute schizophrenia: 12-week results from a prospective longitudinal study.
Zhang Y; Fang X; Fan W; Tang W; Cai J; Song L; Zhang C
Psychopharmacology (Berl); 2018 Apr; 235(4):1191-1198. PubMed ID: 29392373
[TBL] [Abstract][Full Text] [Related]
6. Serum brain-derived neurotrophic factors in Taiwanese patients with drug-naïve first-episode schizophrenia: Effects of antipsychotics.
Chiou YJ; Huang TL
World J Biol Psychiatry; 2017 Aug; 18(5):382-391. PubMed ID: 27643618
[TBL] [Abstract][Full Text] [Related]
7. Decreased BDNF in patients with antipsychotic naïve first episode schizophrenia.
Jindal RD; Pillai AK; Mahadik SP; Eklund K; Montrose DM; Keshavan MS
Schizophr Res; 2010 Jun; 119(1-3):47-51. PubMed ID: 20096541
[TBL] [Abstract][Full Text] [Related]
8. Lower Brain-Derived Neurotropic Factor Levels in Untreated Adolescents With First-Episode Psychosis.
Şimşek Ş; Gençoğlan S; Yüksel T; Kaplan İ; Aktaş H
J Clin Psychopharmacol; 2015 Oct; 35(5):596-9. PubMed ID: 26267416
[TBL] [Abstract][Full Text] [Related]
9. Longitudinal assessment of brain-derived neurotrophic factor in Sardinian psychotic patients (LABSP): a protocol for a prospective observational study.
Primavera D; Manchia M; Deriu L; Tusconi M; Collu R; Scherma M; Fadda P; Fratta W; Carpiniello B
BMJ Open; 2017 May; 7(5):e014938. PubMed ID: 28550022
[TBL] [Abstract][Full Text] [Related]
10. Metabolic adverse effects of olanzapine on cognitive dysfunction: A possible relationship between BDNF and TNF-alpha.
Zhang C; Fang X; Yao P; Mao Y; Cai J; Zhang Y; Chen M; Fan W; Tang W; Song L
Psychoneuroendocrinology; 2017 Jul; 81():138-143. PubMed ID: 28477447
[TBL] [Abstract][Full Text] [Related]
11. Reduced serum BDNF levels in patients with chronic schizophrenic disorder in relapse, who were treated with typical or atypical antipsychotics.
Rizos EN; Papadopoulou A; Laskos E; Michalopoulou PG; Kastania A; Vasilopoulos D; Katsafouros K; Lykouras L
World J Biol Psychiatry; 2010 Mar; 11(2 Pt 2):251-5. PubMed ID: 20218789
[TBL] [Abstract][Full Text] [Related]
12. A practical clinical trial comparing haloperidol, risperidone, and olanzapine for the acute treatment of first-episode nonaffective psychosis.
Crespo-Facorro B; Pérez-Iglesias R; Ramirez-Bonilla M; Martínez-García O; Llorca J; Luis Vázquez-Barquero J
J Clin Psychiatry; 2006 Oct; 67(10):1511-21. PubMed ID: 17107241
[TBL] [Abstract][Full Text] [Related]
13. Plasma orexin A, ghrelin, cholecystokinin, visfatin, leptin and agouti-related protein levels during 6-week olanzapine treatment in first-episode male patients with psychosis.
Basoglu C; Oner O; Gunes C; Semiz UB; Ates AM; Algul A; Ebrinc S; Cetin M; Ozcan O; Ipcioglu O
Int Clin Psychopharmacol; 2010 May; 25(3):165-71. PubMed ID: 21811193
[TBL] [Abstract][Full Text] [Related]
14. Different patterns of longitudinal changes in plasma levels of catecholamine metabolites and brain-derived neurotrophic factor after administration of atypical antipsychotics in first episode untreated schizophrenic patients.
Yoshimura R; Ueda N; Hori H; Ikenouchi-Sugita A; Umene-Nakano W; Nakamura J
World J Biol Psychiatry; 2010 Mar; 11(2 Pt 2):256-61. PubMed ID: 20218790
[TBL] [Abstract][Full Text] [Related]
15. Low serum levels of brain-derived neurotrophic factor in patients with schizophrenia do not elevate after antipsychotic treatment.
Pirildar S; Gönül AS; Taneli F; Akdeniz F
Prog Neuropsychopharmacol Biol Psychiatry; 2004 Jul; 28(4):709-13. PubMed ID: 15276697
[TBL] [Abstract][Full Text] [Related]
16. Decreased BDNF levels in CSF of drug-naive first-episode psychotic subjects: correlation with plasma BDNF and psychopathology.
Pillai A; Kale A; Joshi S; Naphade N; Raju MS; Nasrallah H; Mahadik SP
Int J Neuropsychopharmacol; 2010 May; 13(4):535-9. PubMed ID: 19941699
[TBL] [Abstract][Full Text] [Related]
17. Serum brain-derived neurotrophic factor levels and psychotic symptoms in heroin dependence.
Han B; Zhang XY; Wang DY; Ren WW; Gu YY; Zhu L; Chang YL; Wang LP; Wu CW; Jin QQ; Chen C; Lyu DZ; Zhao JY; Shao B; He JC
Compr Psychiatry; 2015 Oct; 62():80-5. PubMed ID: 26343470
[TBL] [Abstract][Full Text] [Related]
18. Potential diagnostic markers of olanzapine efficiency for acute psychosis: a focus on peripheral biogenic amines.
Taraskina AE; Nasyrova RF; Zabotina AM; Sosin DN; Sosina КА; Ershov EE; Grunina MN; Krupitsky EM
BMC Psychiatry; 2017 Dec; 17(1):394. PubMed ID: 29221470
[TBL] [Abstract][Full Text] [Related]
19. Decreased serum BDNF levels in chronic institutionalized schizophrenia on long-term treatment with typical and atypical antipsychotics.
Xiu MH; Hui L; Dang YF; Hou TD; Zhang CX; Zheng YL; Chen DC; Kosten TR; Zhang XY
Prog Neuropsychopharmacol Biol Psychiatry; 2009 Nov; 33(8):1508-12. PubMed ID: 19720106
[TBL] [Abstract][Full Text] [Related]
20. Effects of olanzapine on brain-derived neurotrophic factor gene promoter activity in SH-SY5Y neuroblastoma cells.
Lee JG; Cho HY; Park SW; Seo MK; Kim YH
Prog Neuropsychopharmacol Biol Psychiatry; 2010 Aug; 34(6):1001-6. PubMed ID: 20546816
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
